Business
BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
Signs Standby Purchase Agreement for $8 million Company Announces VP, Finance LAVAL, QC, July 7 /...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\n Signs Standby Purchase Agreement for $8 million\n Company Announces VP, Finance\n\n\nLAVAL, QC, July 7 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) today\nannounced that it is filing a preliminary short form prospectus in each of the\nprovinces of Canada for a $12,080,018 million rights offering to holders of\nits common shares. All currency figures reported in this press release are\nreported in Canadian dollars.\n\n\nUnder the terms of the rights offering, one right will be issued for each\ncommon share outstanding as of a record date which is yet to be determined.\nHolders of common shares of BELLUS Health resident in Canada (the "Eligible\nShareholders") will be entitled to exercise rights to subscribe for common\nshares of BELLUS Health. Each 0.80 of a right will entitle Eligible\nShareholders to purchase one common share of BELLUS Health at $0.185 (the\n"Subscription Price"). The Subscription Price represents a 25% discount off\nthe volume weighted average price of BELLUS Health's common shares on the\nToronto Stock Exchange during the five (5) trading days immediately preceding\nthis announcement. The rights will be exercisable for at least 21 days\nfollowing the date of mailing of the final prospectus.\n\n\nDue to applicable securities law and regulatory restrictions, only\nEligible Shareholders will be able to exercise rights. The rights agent will\nattempt to sell the rights of holders of common shares other than Eligible\nShareholders and remit the proceeds of any such sale, net of applicable\nexpenses to such other shareholders. Due to such securities law and regulatory\nrestrictions, the offering is not available to holders of securities of BELLUS\nHealth other than holders of common shares.\n\n\nThe rights offering is subject to regulatory approval, including that of\nthe Toronto Stock Exchange.\n\n\nBELLUS Health also announced today the appointment of Mr. Francois\nDesjardins, C.A., to the position of Vice President, Finance. Mr. Desjardins\nhas held the position of Director, Finance and Control at BELLUS Health since\n2003. Mr. Desjardins has worked for companies such as Provigo Inc., Crane\nCanada Inc., and Coopers & Lybrand, and has close to 15 years experience in\nthe biopharmaceutical industry, six of which stem from his tenure as Corporate\nController at Biochem Pharma.\n\n\...